{
    "medicine_id": "17dece9efbed7f13f9b31031135be9a5e5886091",
    "platform_id": "2710",
    "metadata": {
        "name": "Montelukast 5 mg Chewable Tablets",
        "composition": "One chewable tablet contains montelukast sodium which is equivalent to 5 mg montelukast",
        "clinical_particulars": {
            "therapeutic_indications": "Montelukast 5 mg Chewable Tablet is indicated in the treatment of asthma as add on therapy in those 6 to 14 years old patients with mild to moderate persistent asthma who are inadequately controlled on inhaled corticosteroids and in whom as needed short acting beta agonists provide inadequate clinical control of asthma Montelukast 5 mg Chewable Tablet may also be an alternative treatment option to low dose inhaled corticosteroids for 6 to 14 years old patients with mild persistent asthma who do not have a recent history of serious asthma attacks that required oral corticosteroid use and who have demonstrated that they are not capable of using inhaled corticosteroids see section 4 2 Montelukast 5 mg Chewable Tablet is also indicated in the prophylaxis of asthma for 6 to 14 years old patients in which the predominant component is exercise induced bronchoconstriction",
            "contraindications": {
                "disease": "Hypersensitivity to the active substance or to any of the excipients listed in section 6 1",
                "pregnancy": "Applicable",
                "machine_ops": "Applicable",
                "excipients": "Mannitol;Cellulose microcrystalline;Croscarmellose sodium;Magnesium stearate;Sodium laurilsulfate;Silica, colloidal anhydrous;Aspartame (E 951);Cherry flavour 501027 AP 0551 (contains Maize maltodextrin, Benzyl alcohol (E 1519), Triethyl;;citrate (E 1505)",
                "incompatibilities": "Not applicable."
            }
        },
        "revision_date": "2023-05-13"
    }
}